 Irina Petrache
Concepts (587)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Emphysema | 35 | 2024 | 244 | 10.290 |
Why?
| | Ceramides | 23 | 2023 | 104 | 5.230 |
Why?
| | alpha 1-Antitrypsin | 15 | 2023 | 103 | 5.190 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 24 | 2024 | 953 | 4.840 |
Why?
| | Lung | 54 | 2025 | 3752 | 4.610 |
Why?
| | Endothelial Cells | 25 | 2025 | 701 | 4.360 |
Why?
| | Smoking | 30 | 2020 | 1466 | 4.060 |
Why?
| | Apoptosis | 38 | 2020 | 2438 | 3.600 |
Why?
| | Cigarette Smoking | 8 | 2022 | 87 | 3.500 |
Why?
| | Lung Injury | 11 | 2023 | 199 | 3.450 |
Why?
| | Smoke | 12 | 2021 | 132 | 3.150 |
Why?
| | Electronic Nicotine Delivery Systems | 7 | 2023 | 89 | 2.930 |
Why?
| | Emphysema | 10 | 2023 | 95 | 2.520 |
Why?
| | Sphingolipids | 7 | 2018 | 69 | 2.280 |
Why?
| | alpha 1-Antitrypsin Deficiency | 8 | 2019 | 61 | 2.230 |
Why?
| | Pulmonary Alveoli | 15 | 2018 | 366 | 2.180 |
Why?
| | Macrophages, Alveolar | 5 | 2021 | 380 | 2.130 |
Why?
| | Vaping | 3 | 2023 | 55 | 1.620 |
Why?
| | Sphingomyelin Phosphodiesterase | 6 | 2023 | 18 | 1.540 |
Why?
| | Animals | 88 | 2025 | 34600 | 1.440 |
Why?
| | Endothelium, Vascular | 11 | 2023 | 872 | 1.420 |
Why?
| | Tobacco Products | 5 | 2021 | 111 | 1.410 |
Why?
| | Hypertension, Pulmonary | 9 | 2025 | 1741 | 1.410 |
Why?
| | Microvessels | 4 | 2021 | 79 | 1.390 |
Why?
| | Mice | 57 | 2024 | 16644 | 1.370 |
Why?
| | Signal Transduction | 19 | 2020 | 4838 | 1.260 |
Why?
| | Oxidative Stress | 13 | 2020 | 1192 | 1.260 |
Why?
| | Cells, Cultured | 23 | 2021 | 4010 | 1.220 |
Why?
| | Autophagy | 7 | 2021 | 267 | 1.200 |
Why?
| | Acute Lung Injury | 3 | 2021 | 264 | 1.190 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2017 | 1192 | 1.180 |
Why?
| | Alveolar Epithelial Cells | 3 | 2018 | 97 | 1.150 |
Why?
| | Disease Models, Animal | 16 | 2022 | 3953 | 1.120 |
Why?
| | Mice, Inbred C57BL | 27 | 2022 | 5284 | 1.080 |
Why?
| | Pneumonia | 5 | 2021 | 599 | 1.050 |
Why?
| | Caspase 3 | 7 | 2016 | 229 | 1.020 |
Why?
| | Receptors, Estrogen | 3 | 2014 | 429 | 1.000 |
Why?
| | Pulmonary Artery | 10 | 2022 | 1030 | 0.990 |
Why?
| | Membrane Proteins | 5 | 2022 | 1109 | 0.980 |
Why?
| | Hypoxia | 6 | 2020 | 1035 | 0.960 |
Why?
| | Adipose Tissue | 5 | 2017 | 592 | 0.960 |
Why?
| | MicroRNAs | 2 | 2022 | 677 | 0.930 |
Why?
| | Rats | 22 | 2017 | 5173 | 0.930 |
Why?
| | Humans | 100 | 2025 | 129126 | 0.920 |
Why?
| | Neovascularization, Physiologic | 3 | 2020 | 172 | 0.910 |
Why?
| | Tobacco Smoke Pollution | 4 | 2018 | 230 | 0.900 |
Why?
| | Endothelium | 4 | 2023 | 107 | 0.900 |
Why?
| | Up-Regulation | 10 | 2020 | 828 | 0.900 |
Why?
| | Endocytosis | 3 | 2016 | 161 | 0.890 |
Why?
| | Vascular System Injuries | 1 | 2023 | 73 | 0.790 |
Why?
| | Phagocytosis | 3 | 2021 | 364 | 0.740 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 4 | 0.740 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 4 | 0.740 |
Why?
| | Lysophospholipase | 1 | 2021 | 10 | 0.740 |
Why?
| | Rats, Sprague-Dawley | 14 | 2018 | 2245 | 0.730 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2020 | 14 | 0.680 |
Why?
| | Translocation, Genetic | 1 | 2020 | 98 | 0.670 |
Why?
| | Glucosylceramides | 1 | 2019 | 6 | 0.670 |
Why?
| | Immunoglobulins | 1 | 2020 | 157 | 0.660 |
Why?
| | Hyaluronic Acid | 2 | 2020 | 212 | 0.660 |
Why?
| | Estradiol | 3 | 2018 | 497 | 0.640 |
Why?
| | Mice, Knockout | 11 | 2021 | 2765 | 0.630 |
Why?
| | Epithelial Cells | 10 | 2022 | 1036 | 0.630 |
Why?
| | Glycoproteins | 1 | 2021 | 337 | 0.630 |
Why?
| | Macrophages | 4 | 2021 | 1466 | 0.620 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 1 | 2019 | 23 | 0.620 |
Why?
| | Enzyme Inhibitors | 4 | 2018 | 811 | 0.620 |
Why?
| | Influenza, Human | 2 | 2022 | 601 | 0.610 |
Why?
| | Antibodies, Neutralizing | 2 | 2019 | 264 | 0.600 |
Why?
| | Alpha-Globulins | 1 | 2018 | 20 | 0.600 |
Why?
| | Lysosomes | 2 | 2021 | 136 | 0.600 |
Why?
| | Heterocyclic Compounds | 1 | 2018 | 17 | 0.600 |
Why?
| | Xeroderma Pigmentosum | 1 | 2018 | 7 | 0.590 |
Why?
| | Sphingosine | 5 | 2015 | 36 | 0.590 |
Why?
| | Lung Diseases | 4 | 2025 | 723 | 0.590 |
Why?
| | Neoplasm Proteins | 5 | 2019 | 421 | 0.590 |
Why?
| | Oncostatin M | 1 | 2017 | 6 | 0.580 |
Why?
| | Sphingosine N-Acyltransferase | 2 | 2018 | 5 | 0.580 |
Why?
| | Bronchoalveolar Lavage Fluid | 7 | 2018 | 627 | 0.580 |
Why?
| | RNA-Binding Proteins | 5 | 2019 | 388 | 0.570 |
Why?
| | Metformin | 1 | 2021 | 313 | 0.570 |
Why?
| | Thorax | 2 | 2022 | 41 | 0.560 |
Why?
| | Multiprotein Complexes | 1 | 2018 | 147 | 0.530 |
Why?
| | Cell Death | 4 | 2019 | 348 | 0.530 |
Why?
| | Inflammation | 8 | 2024 | 2668 | 0.530 |
Why?
| | Cell Movement | 4 | 2020 | 939 | 0.520 |
Why?
| | DNA Repair | 1 | 2018 | 205 | 0.520 |
Why?
| | Male | 44 | 2024 | 63201 | 0.520 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 61 | 0.490 |
Why?
| | DNA Damage | 1 | 2018 | 364 | 0.490 |
Why?
| | Scavenger Receptors, Class B | 1 | 2015 | 11 | 0.490 |
Why?
| | Genetic Predisposition to Disease | 3 | 2020 | 2267 | 0.490 |
Why?
| | Telemetry | 1 | 2015 | 40 | 0.480 |
Why?
| | Cosmic Radiation | 1 | 2014 | 6 | 0.480 |
Why?
| | ADAM Proteins | 3 | 2022 | 58 | 0.470 |
Why?
| | Cytokines | 9 | 2019 | 1987 | 0.470 |
Why?
| | Mice, Transgenic | 8 | 2022 | 2079 | 0.470 |
Why?
| | Oxidoreductases | 4 | 2011 | 90 | 0.460 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 83 | 0.460 |
Why?
| | Female | 35 | 2024 | 68517 | 0.460 |
Why?
| | Transcytosis | 1 | 2014 | 8 | 0.460 |
Why?
| | Alginates | 1 | 2014 | 46 | 0.450 |
Why?
| | Palmitic Acids | 1 | 2014 | 10 | 0.450 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2013 | 283 | 0.450 |
Why?
| | Receptors, Lysosphingolipid | 2 | 2014 | 14 | 0.450 |
Why?
| | Thoracic Vertebrae | 1 | 2014 | 73 | 0.440 |
Why?
| | Caspase Inhibitors | 3 | 2011 | 77 | 0.440 |
Why?
| | Cell Proliferation | 9 | 2020 | 2347 | 0.440 |
Why?
| | Nicotinic Agonists | 1 | 2015 | 125 | 0.440 |
Why?
| | Spinal Injuries | 1 | 2014 | 52 | 0.440 |
Why?
| | Enzyme Activation | 8 | 2015 | 799 | 0.430 |
Why?
| | Stem Cell Transplantation | 2 | 2015 | 165 | 0.430 |
Why?
| | Trypsin Inhibitors | 2 | 2017 | 5 | 0.410 |
Why?
| | Interleukin-6 | 1 | 2016 | 718 | 0.410 |
Why?
| | Lysophospholipids | 5 | 2015 | 68 | 0.400 |
Why?
| | Tracheostomy | 1 | 2014 | 119 | 0.400 |
Why?
| | Nicotine | 1 | 2015 | 303 | 0.400 |
Why?
| | Pseudomonas Infections | 1 | 2014 | 213 | 0.390 |
Why?
| | Cystic Fibrosis | 2 | 2014 | 1063 | 0.380 |
Why?
| | Metabolomics | 5 | 2018 | 599 | 0.380 |
Why?
| | Pseudomonas aeruginosa | 1 | 2014 | 336 | 0.380 |
Why?
| | Estrogens | 1 | 2014 | 354 | 0.370 |
Why?
| | Photons | 1 | 2011 | 64 | 0.360 |
Why?
| | Exercise Therapy | 1 | 2015 | 416 | 0.360 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2021 | 51 | 0.360 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 313 | 0.350 |
Why?
| | Stress, Physiological | 1 | 2014 | 412 | 0.350 |
Why?
| | Cell Differentiation | 2 | 2018 | 1901 | 0.350 |
Why?
| | Virus Diseases | 2 | 2023 | 209 | 0.340 |
Why?
| | Adult Stem Cells | 1 | 2010 | 39 | 0.340 |
Why?
| | Hemodynamics | 1 | 2015 | 1084 | 0.340 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2014 | 1945 | 0.330 |
Why?
| | Pancreatic Elastase | 2 | 2021 | 59 | 0.330 |
Why?
| | Caspases | 3 | 2011 | 242 | 0.330 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2024 | 182 | 0.310 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2021 | 380 | 0.310 |
Why?
| | Phenotype | 7 | 2020 | 3058 | 0.310 |
Why?
| | Superoxide Dismutase | 3 | 2020 | 328 | 0.300 |
Why?
| | Fingolimod Hydrochloride | 3 | 2022 | 36 | 0.300 |
Why?
| | Vascular Remodeling | 4 | 2025 | 181 | 0.300 |
Why?
| | Diagnostic Imaging | 1 | 2011 | 330 | 0.300 |
Why?
| | Mass Spectrometry | 4 | 2018 | 660 | 0.280 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 538 | 0.280 |
Why?
| | Fibrinolysin | 1 | 2007 | 17 | 0.280 |
Why?
| | Transcription Factors | 2 | 2012 | 1632 | 0.280 |
Why?
| | Heart | 1 | 2011 | 639 | 0.280 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1423 | 0.270 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2016 | 133 | 0.270 |
Why?
| | Lipopolysaccharides | 4 | 2023 | 856 | 0.270 |
Why?
| | RNA, Small Interfering | 3 | 2018 | 571 | 0.270 |
Why?
| | Biomarkers | 8 | 2021 | 3896 | 0.260 |
Why?
| | Thrombin | 1 | 2007 | 142 | 0.260 |
Why?
| | Electric Impedance | 3 | 2015 | 101 | 0.260 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 4 | 2012 | 89 | 0.250 |
Why?
| | Gene Expression Regulation | 5 | 2020 | 2508 | 0.250 |
Why?
| | ADAM17 Protein | 2 | 2017 | 31 | 0.250 |
Why?
| | Mice, Inbred DBA | 2 | 2019 | 186 | 0.250 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 315 | 0.240 |
Why?
| | Leukocytes | 3 | 2022 | 303 | 0.240 |
Why?
| | Cell Adhesion | 2 | 2020 | 445 | 0.240 |
Why?
| | Caspase 6 | 2 | 2016 | 2 | 0.230 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2015 | 126 | 0.230 |
Why?
| | Caspase 7 | 2 | 2016 | 20 | 0.230 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2541 | 0.230 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 634 | 0.230 |
Why?
| | Chemokine CX3CL1 | 1 | 2023 | 23 | 0.220 |
Why?
| | Capillary Permeability | 2 | 2015 | 131 | 0.220 |
Why?
| | Homeostasis | 3 | 2018 | 605 | 0.210 |
Why?
| | Biomedical Technology | 1 | 2024 | 40 | 0.210 |
Why?
| | Cell Culture Techniques | 2 | 2019 | 346 | 0.210 |
Why?
| | Receptors, CXCR3 | 2 | 2013 | 16 | 0.210 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2003 | 20 | 0.210 |
Why?
| | Monocytes | 4 | 2023 | 543 | 0.210 |
Why?
| | Pulmonary Medicine | 1 | 2024 | 80 | 0.210 |
Why?
| | rho GTP-Binding Proteins | 1 | 2003 | 62 | 0.200 |
Why?
| | Cell Line | 4 | 2017 | 2737 | 0.200 |
Why?
| | Middle Aged | 11 | 2022 | 31079 | 0.200 |
Why?
| | Respiratory System | 1 | 2024 | 153 | 0.200 |
Why?
| | Oxygen Consumption | 2 | 2022 | 675 | 0.190 |
Why?
| | Cell Adhesion Molecules | 2 | 2015 | 172 | 0.190 |
Why?
| | X-Ray Microtomography | 2 | 2022 | 84 | 0.190 |
Why?
| | Primary Cell Culture | 2 | 2013 | 159 | 0.190 |
Why?
| | Congresses as Topic | 1 | 2023 | 215 | 0.190 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 1230 | 0.190 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 245 | 0.190 |
Why?
| | Flow Cytometry | 4 | 2015 | 1142 | 0.190 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 11 | 0.190 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 8 | 0.190 |
Why?
| | Chitinases | 1 | 2021 | 9 | 0.190 |
Why?
| | Influenza A virus | 1 | 2022 | 102 | 0.180 |
Why?
| | Societies, Medical | 2 | 2023 | 749 | 0.180 |
Why?
| | CD11 Antigens | 1 | 2021 | 29 | 0.180 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2021 | 40 | 0.180 |
Why?
| | CD11b Antigen | 1 | 2021 | 59 | 0.180 |
Why?
| | Cell Size | 1 | 2021 | 87 | 0.180 |
Why?
| | Cytoskeleton | 3 | 2011 | 180 | 0.180 |
Why?
| | Lectins | 1 | 2021 | 46 | 0.180 |
Why?
| | Dronabinol | 1 | 2023 | 166 | 0.180 |
Why?
| | Kinetics | 3 | 2015 | 1617 | 0.180 |
Why?
| | Risk Factors | 5 | 2024 | 9768 | 0.180 |
Why?
| | Protein Inhibitors of Activated STAT | 1 | 2020 | 5 | 0.180 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 257 | 0.180 |
Why?
| | Inhalation Exposure | 1 | 2021 | 91 | 0.180 |
Why?
| | Endothelial Progenitor Cells | 1 | 2020 | 20 | 0.180 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 2020 | 28 | 0.180 |
Why?
| | Integrin beta1 | 1 | 2020 | 19 | 0.180 |
Why?
| | Blotting, Western | 4 | 2011 | 1169 | 0.170 |
Why?
| | Microtubules | 1 | 2003 | 260 | 0.170 |
Why?
| | Sirolimus | 1 | 2021 | 189 | 0.170 |
Why?
| | Receptors, CXCR4 | 2 | 2018 | 82 | 0.170 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2020 | 70 | 0.170 |
Why?
| | Stem Cell Niche | 1 | 2020 | 51 | 0.170 |
Why?
| | Lactic Acid | 1 | 2022 | 295 | 0.170 |
Why?
| | Tobacco Smoking | 1 | 2020 | 25 | 0.170 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2020 | 66 | 0.170 |
Why?
| | Stromal Cells | 2 | 2017 | 105 | 0.170 |
Why?
| | Ischemia | 2 | 2018 | 395 | 0.170 |
Why?
| | Oxidants | 2 | 2011 | 106 | 0.170 |
Why?
| | Biological Assay | 2 | 2021 | 118 | 0.160 |
Why?
| | Cell Membrane | 3 | 2013 | 722 | 0.160 |
Why?
| | Collagen Type V | 2 | 2009 | 3 | 0.160 |
Why?
| | Case-Control Studies | 2 | 2017 | 3342 | 0.160 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2020 | 153 | 0.160 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 1 | 2019 | 17 | 0.160 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 166 | 0.160 |
Why?
| | Exercise Test | 1 | 2022 | 615 | 0.160 |
Why?
| | Serine C-Palmitoyltransferase | 3 | 2008 | 6 | 0.160 |
Why?
| | Fatty Acids | 1 | 2022 | 415 | 0.150 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2020 | 371 | 0.150 |
Why?
| | beta Catenin | 1 | 2020 | 219 | 0.150 |
Why?
| | Paclitaxel | 2 | 2014 | 215 | 0.150 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2013 | 162 | 0.150 |
Why?
| | Hot Temperature | 1 | 2021 | 364 | 0.150 |
Why?
| | Cell Survival | 3 | 2018 | 1077 | 0.150 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2014 | 186 | 0.150 |
Why?
| | Eosinophils | 1 | 2021 | 324 | 0.150 |
Why?
| | Databases, Chemical | 1 | 2018 | 6 | 0.150 |
Why?
| | Benzylamines | 1 | 2018 | 41 | 0.150 |
Why?
| | Oxygen | 2 | 2014 | 902 | 0.150 |
Why?
| | Parenchymal Tissue | 1 | 2018 | 6 | 0.150 |
Why?
| | Estrogen Receptor beta | 1 | 2018 | 35 | 0.150 |
Why?
| | Imipramine | 1 | 2018 | 12 | 0.150 |
Why?
| | Mucociliary Clearance | 1 | 2018 | 42 | 0.150 |
Why?
| | Morphine | 2 | 2009 | 129 | 0.150 |
Why?
| | Chemokine CXCL12 | 1 | 2018 | 77 | 0.150 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 140 | 0.140 |
Why?
| | Gene Expression | 2 | 2021 | 1462 | 0.140 |
Why?
| | Carbon Monoxide | 1 | 2018 | 68 | 0.140 |
Why?
| | Academic Medical Centers | 1 | 2020 | 479 | 0.140 |
Why?
| | Adult | 10 | 2022 | 35512 | 0.140 |
Why?
| | Disease Outbreaks | 1 | 2020 | 343 | 0.140 |
Why?
| | Cell Hypoxia | 4 | 2020 | 229 | 0.140 |
Why?
| | Leukocyte Elastase | 1 | 2017 | 74 | 0.140 |
Why?
| | Neovascularization, Pathologic | 2 | 2012 | 291 | 0.140 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 519 | 0.140 |
Why?
| | Transcriptome | 3 | 2018 | 883 | 0.140 |
Why?
| | Bone Marrow | 1 | 2018 | 268 | 0.130 |
Why?
| | THP-1 Cells | 1 | 2016 | 24 | 0.130 |
Why?
| | High-Intensity Interval Training | 1 | 2016 | 24 | 0.130 |
Why?
| | Spinal Cord | 2 | 2009 | 354 | 0.130 |
Why?
| | Adipocytes | 1 | 2018 | 204 | 0.130 |
Why?
| | Sleep Apnea Syndromes | 1 | 2017 | 79 | 0.130 |
Why?
| | Time Factors | 3 | 2018 | 6518 | 0.130 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2011 | 313 | 0.130 |
Why?
| | Lung Transplantation | 2 | 2009 | 276 | 0.130 |
Why?
| | Bronchi | 1 | 2017 | 240 | 0.130 |
Why?
| | Protein Binding | 3 | 2018 | 2106 | 0.130 |
Why?
| | Pandemics | 2 | 2021 | 1491 | 0.130 |
Why?
| | Plasma | 1 | 2017 | 201 | 0.120 |
Why?
| | Protein Kinases | 1 | 2018 | 309 | 0.120 |
Why?
| | Monocrotaline | 1 | 2015 | 21 | 0.120 |
Why?
| | I-kappa B Proteins | 2 | 2013 | 73 | 0.120 |
Why?
| | Mice, 129 Strain | 2 | 2012 | 80 | 0.120 |
Why?
| | Aging | 2 | 2021 | 1772 | 0.120 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2015 | 50 | 0.120 |
Why?
| | Neutrophils | 1 | 2021 | 1195 | 0.120 |
Why?
| | Actins | 3 | 2018 | 402 | 0.120 |
Why?
| | Ventricular Pressure | 1 | 2015 | 43 | 0.120 |
Why?
| | Insulin-Secreting Cells | 1 | 2020 | 366 | 0.120 |
Why?
| | Delivery of Health Care | 1 | 2022 | 894 | 0.120 |
Why?
| | Myelopoiesis | 1 | 2015 | 7 | 0.120 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.120 |
Why?
| | Binding, Competitive | 1 | 2015 | 199 | 0.120 |
Why?
| | Cathepsin E | 1 | 2014 | 1 | 0.120 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 378 | 0.120 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 136 | 0.120 |
Why?
| | Cell Membrane Permeability | 1 | 2015 | 80 | 0.120 |
Why?
| | Culture Media, Conditioned | 1 | 2015 | 108 | 0.120 |
Why?
| | Collagen Type VI | 1 | 2014 | 4 | 0.120 |
Why?
| | Immunoblotting | 1 | 2015 | 300 | 0.120 |
Why?
| | Hexuronic Acids | 1 | 2014 | 23 | 0.120 |
Why?
| | Glucuronic Acid | 1 | 2014 | 25 | 0.120 |
Why?
| | Polysaccharide-Lyases | 1 | 2014 | 11 | 0.120 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2739 | 0.110 |
Why?
| | Arterial Pressure | 1 | 2015 | 118 | 0.110 |
Why?
| | Mice, Inbred C3H | 1 | 2014 | 274 | 0.110 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2015 | 201 | 0.110 |
Why?
| | Mitochondrial Dynamics | 1 | 2014 | 37 | 0.110 |
Why?
| | Propylene Glycols | 2 | 2014 | 25 | 0.110 |
Why?
| | Metabolome | 1 | 2017 | 318 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2010 | 431 | 0.110 |
Why?
| | Hyperoxia | 1 | 2015 | 87 | 0.110 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2014 | 67 | 0.110 |
Why?
| | Dehydroepiandrosterone | 1 | 2014 | 51 | 0.110 |
Why?
| | Asthma | 2 | 2020 | 2219 | 0.110 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2016 | 228 | 0.110 |
Why?
| | HMGB1 Protein | 1 | 2014 | 48 | 0.110 |
Why?
| | Ligands | 3 | 2023 | 614 | 0.110 |
Why?
| | Paracrine Communication | 1 | 2014 | 61 | 0.110 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2013 | 57 | 0.110 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2013 | 48 | 0.110 |
Why?
| | HIV Infections | 3 | 2017 | 2715 | 0.110 |
Why?
| | Ventricular Remodeling | 2 | 2015 | 258 | 0.110 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 183 | 0.110 |
Why?
| | Oligopeptides | 2 | 2014 | 258 | 0.110 |
Why?
| | Glycolysis | 1 | 2015 | 293 | 0.110 |
Why?
| | United States | 4 | 2024 | 13939 | 0.110 |
Why?
| | Virulence | 1 | 2014 | 254 | 0.110 |
Why?
| | Calpain | 1 | 2013 | 53 | 0.110 |
Why?
| | Glycerylphosphorylcholine | 1 | 2013 | 6 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2006 | 501 | 0.100 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2013 | 34 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2017 | 408 | 0.100 |
Why?
| | Dermatitis, Contact | 1 | 2013 | 19 | 0.100 |
Why?
| | Bronchitis, Chronic | 1 | 2013 | 19 | 0.100 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 1943 | 0.100 |
Why?
| | Platelet Activating Factor | 1 | 2013 | 74 | 0.100 |
Why?
| | MAP Kinase Signaling System | 2 | 2012 | 303 | 0.100 |
Why?
| | Ventricular Function, Right | 1 | 2015 | 276 | 0.100 |
Why?
| | Cattle | 3 | 2008 | 962 | 0.100 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2013 | 43 | 0.100 |
Why?
| | Neuralgia | 1 | 2014 | 120 | 0.100 |
Why?
| | Lung Compliance | 1 | 2012 | 45 | 0.100 |
Why?
| | Proteolysis | 1 | 2013 | 162 | 0.100 |
Why?
| | Liposomes | 1 | 2014 | 168 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2065 | 0.100 |
Why?
| | Drug Tolerance | 2 | 2009 | 83 | 0.100 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5070 | 0.100 |
Why?
| | Estrogen Antagonists | 1 | 2012 | 45 | 0.100 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 71 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 421 | 0.090 |
Why?
| | Airway Remodeling | 1 | 2012 | 58 | 0.090 |
Why?
| | Cardiac Output | 1 | 2012 | 155 | 0.090 |
Why?
| | Atmosphere Exposure Chambers | 1 | 2011 | 5 | 0.090 |
Why?
| | Catalase | 1 | 2011 | 122 | 0.090 |
Why?
| | Polymerase Chain Reaction | 2 | 2015 | 1021 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2014 | 1271 | 0.090 |
Why?
| | Microcirculation | 1 | 2011 | 137 | 0.090 |
Why?
| | Bronchioles | 1 | 2011 | 22 | 0.090 |
Why?
| | Goblet Cells | 1 | 2011 | 18 | 0.090 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2011 | 150 | 0.090 |
Why?
| | Permeability | 1 | 2011 | 156 | 0.090 |
Why?
| | Analgesics, Opioid | 2 | 2009 | 908 | 0.090 |
Why?
| | Immunization, Passive | 1 | 2011 | 85 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2013 | 374 | 0.090 |
Why?
| | Ceramidases | 1 | 2010 | 3 | 0.090 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 206 | 0.090 |
Why?
| | Inflammasomes | 1 | 2012 | 128 | 0.090 |
Why?
| | Carcinogens | 1 | 2011 | 110 | 0.090 |
Why?
| | Phosphorylation | 1 | 2015 | 1687 | 0.090 |
Why?
| | Acetylcysteine | 1 | 2011 | 144 | 0.090 |
Why?
| | Plant Extracts | 1 | 2012 | 179 | 0.090 |
Why?
| | Jurkat Cells | 1 | 2010 | 131 | 0.090 |
Why?
| | Mice, Inbred Strains | 1 | 2011 | 402 | 0.090 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2010 | 52 | 0.090 |
Why?
| | Stem Cells | 1 | 2015 | 579 | 0.090 |
Why?
| | Aged | 5 | 2020 | 22089 | 0.090 |
Why?
| | Testosterone | 1 | 2014 | 379 | 0.090 |
Why?
| | Perfusion | 1 | 2011 | 188 | 0.090 |
Why?
| | Exercise | 1 | 2022 | 1950 | 0.090 |
Why?
| | Transplantation, Heterologous | 1 | 2010 | 187 | 0.080 |
Why?
| | Adaptation, Physiological | 1 | 2014 | 515 | 0.080 |
Why?
| | Biosensing Techniques | 1 | 2011 | 114 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2017 | 2676 | 0.080 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 42 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 973 | 0.080 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2012 | 391 | 0.080 |
Why?
| | Posterior Horn Cells | 1 | 2009 | 5 | 0.080 |
Why?
| | Pulmonary Circulation | 1 | 2011 | 416 | 0.080 |
Why?
| | Oxidation-Reduction | 3 | 2022 | 1002 | 0.080 |
Why?
| | Immunosuppressive Agents | 2 | 2014 | 690 | 0.080 |
Why?
| | Clathrin | 1 | 2009 | 26 | 0.080 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1671 | 0.080 |
Why?
| | Transplantation Tolerance | 1 | 2009 | 34 | 0.080 |
Why?
| | Mutation | 1 | 2020 | 3700 | 0.080 |
Why?
| | Peptide Fragments | 1 | 2013 | 686 | 0.080 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 89 | 0.080 |
Why?
| | Transplantation, Homologous | 1 | 2010 | 396 | 0.080 |
Why?
| | Peroxynitrous Acid | 1 | 2008 | 14 | 0.080 |
Why?
| | Heart Ventricles | 1 | 2014 | 768 | 0.080 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2006 | 67 | 0.080 |
Why?
| | Cell Line, Tumor | 3 | 2011 | 3184 | 0.080 |
Why?
| | Protein Precursors | 1 | 2009 | 126 | 0.080 |
Why?
| | Cyclosporine | 1 | 2009 | 169 | 0.080 |
Why?
| | Software | 1 | 2013 | 610 | 0.080 |
Why?
| | Transcription, Genetic | 2 | 2013 | 1403 | 0.080 |
Why?
| | Histocompatibility Antigens | 1 | 2009 | 107 | 0.080 |
Why?
| | Pyrroles | 1 | 2009 | 192 | 0.080 |
Why?
| | Superoxide Dismutase-1 | 1 | 2008 | 9 | 0.080 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2008 | 35 | 0.070 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2020 | 245 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2014 | 805 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 269 | 0.070 |
Why?
| | Sex Factors | 1 | 2014 | 1953 | 0.070 |
Why?
| | Patch-Clamp Techniques | 1 | 2009 | 262 | 0.070 |
Why?
| | Glycerophospholipids | 2 | 2018 | 32 | 0.070 |
Why?
| | Obesity | 2 | 2020 | 2863 | 0.070 |
Why?
| | Hypersensitivity | 1 | 2011 | 250 | 0.070 |
Why?
| | Transglutaminases | 1 | 2008 | 153 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2009 | 360 | 0.070 |
Why?
| | Caspase 9 | 2 | 2008 | 54 | 0.070 |
Why?
| | Superoxides | 1 | 2008 | 196 | 0.070 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 308 | 0.070 |
Why?
| | Organ Size | 1 | 2008 | 441 | 0.070 |
Why?
| | Antibody Formation | 1 | 2008 | 288 | 0.070 |
Why?
| | Antiviral Agents | 2 | 2023 | 706 | 0.070 |
Why?
| | Cell-Free System | 1 | 2006 | 47 | 0.070 |
Why?
| | Indoles | 1 | 2009 | 372 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2020 | 2437 | 0.070 |
Why?
| | Cisplatin | 1 | 2008 | 298 | 0.070 |
Why?
| | Capillaries | 1 | 2006 | 92 | 0.060 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 1046 | 0.060 |
Why?
| | Antigens, CD | 2 | 2011 | 483 | 0.060 |
Why?
| | Graft Rejection | 1 | 2009 | 558 | 0.060 |
Why?
| | Fumonisins | 1 | 2005 | 2 | 0.060 |
Why?
| | Adenoviridae | 1 | 2006 | 190 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1640 | 0.060 |
Why?
| | Weight Loss | 1 | 2010 | 724 | 0.060 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2005 | 51 | 0.060 |
Why?
| | Acyltransferases | 1 | 2005 | 53 | 0.060 |
Why?
| | Regeneration | 1 | 2006 | 175 | 0.060 |
Why?
| | Deoxyguanosine | 1 | 2004 | 24 | 0.060 |
Why?
| | Blood Pressure | 1 | 2012 | 1735 | 0.060 |
Why?
| | Disease Progression | 1 | 2012 | 2613 | 0.060 |
Why?
| | Immunoglobulin G | 1 | 2008 | 846 | 0.060 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 20 | 0.060 |
Why?
| | Supreme Court Decisions | 1 | 2023 | 11 | 0.050 |
Why?
| | Stress Fibers | 1 | 2003 | 18 | 0.050 |
Why?
| | Adherens Junctions | 1 | 2003 | 26 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2003 | 83 | 0.050 |
Why?
| | Caspase 8 | 1 | 2003 | 48 | 0.050 |
Why?
| | Ovarian Neoplasms | 1 | 2008 | 490 | 0.050 |
Why?
| | Myosins | 1 | 2003 | 133 | 0.050 |
Why?
| | rho-Associated Kinases | 1 | 2003 | 83 | 0.050 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1359 | 0.050 |
Why?
| | Sphingomyelins | 2 | 2015 | 29 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 274 | 0.050 |
Why?
| | Trans-Activators | 1 | 2004 | 381 | 0.050 |
Why?
| | Imidazoles | 1 | 2003 | 229 | 0.050 |
Why?
| | Cell Communication | 1 | 2023 | 299 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2329 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2023 | 371 | 0.050 |
Why?
| | Autophagosomes | 1 | 2021 | 19 | 0.050 |
Why?
| | Epithelium | 1 | 2022 | 306 | 0.050 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 41 | 0.040 |
Why?
| | Autoantibodies | 1 | 2008 | 1465 | 0.040 |
Why?
| | Antineoplastic Agents | 2 | 2009 | 2060 | 0.040 |
Why?
| | Fever | 1 | 2022 | 301 | 0.040 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2020 | 8 | 0.040 |
Why?
| | Neurons | 1 | 2008 | 1456 | 0.040 |
Why?
| | Transcription Factor RelA | 1 | 2020 | 82 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 109 | 0.040 |
Why?
| | Pyridines | 1 | 2003 | 477 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 101 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2023 | 732 | 0.040 |
Why?
| | Rats, Inbred WKY | 2 | 2009 | 33 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 757 | 0.040 |
Why?
| | Propensity Score | 1 | 2020 | 265 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2020 | 664 | 0.040 |
Why?
| | Cohort Studies | 2 | 2020 | 5407 | 0.040 |
Why?
| | Swine | 1 | 2021 | 745 | 0.040 |
Why?
| | Cell Lineage | 1 | 2020 | 334 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2020 | 356 | 0.040 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2018 | 21 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2020 | 238 | 0.040 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2018 | 20 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2022 | 493 | 0.040 |
Why?
| | Propionates | 1 | 2018 | 33 | 0.040 |
Why?
| | Odds Ratio | 1 | 2020 | 1025 | 0.040 |
Why?
| | Protein Stability | 1 | 2018 | 161 | 0.040 |
Why?
| | Vital Capacity | 1 | 2018 | 291 | 0.040 |
Why?
| | Nitriles | 1 | 2018 | 161 | 0.040 |
Why?
| | Betacoronavirus | 1 | 2020 | 252 | 0.040 |
Why?
| | Estrogen Receptor alpha | 1 | 2018 | 134 | 0.030 |
Why?
| | Sample Size | 1 | 2017 | 115 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1010 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1337 | 0.030 |
Why?
| | RNA | 1 | 2023 | 883 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 732 | 0.030 |
Why?
| | HIV | 1 | 2017 | 226 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 231 | 0.030 |
Why?
| | Weight Gain | 1 | 2020 | 505 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 117 | 0.030 |
Why?
| | Antioxidants | 2 | 2013 | 543 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1707 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 1979 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 342 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 338 | 0.030 |
Why?
| | NF-kappa B | 2 | 2010 | 652 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| | Administration, Intravenous | 1 | 2015 | 137 | 0.030 |
Why?
| | Physical Endurance | 1 | 2016 | 269 | 0.030 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2015 | 74 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 53 | 0.030 |
Why?
| | Interleukin-23 Subunit p19 | 1 | 2014 | 6 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 451 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 103 | 0.030 |
Why?
| | Young Adult | 1 | 2011 | 12389 | 0.030 |
Why?
| | Quinazolinones | 1 | 2014 | 19 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 983 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 133 | 0.030 |
Why?
| | Indans | 1 | 2014 | 10 | 0.030 |
Why?
| | Oxadiazoles | 1 | 2014 | 34 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 129 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2022 | 14571 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2015 | 328 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2016 | 229 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 347 | 0.030 |
Why?
| | Anilides | 1 | 2014 | 73 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 583 | 0.030 |
Why?
| | Thiazoles | 1 | 2014 | 115 | 0.030 |
Why?
| | Organophosphonates | 1 | 2014 | 91 | 0.030 |
Why?
| | Cricetulus | 1 | 2013 | 104 | 0.030 |
Why?
| | Phosphatidylserines | 1 | 2014 | 88 | 0.030 |
Why?
| | CHO Cells | 1 | 2013 | 150 | 0.030 |
Why?
| | Thiophenes | 1 | 2014 | 119 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2020 | 790 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1567 | 0.030 |
Why?
| | Cricetinae | 1 | 2013 | 275 | 0.030 |
Why?
| | Dinitrofluorobenzene | 1 | 2013 | 7 | 0.030 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 2013 | 21 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 584 | 0.030 |
Why?
| | Lipid Bilayers | 1 | 2014 | 97 | 0.030 |
Why?
| | Phosphatidylcholines | 1 | 2014 | 146 | 0.030 |
Why?
| | Culture Media, Serum-Free | 1 | 2012 | 49 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2013 | 143 | 0.030 |
Why?
| | Lymphocyte Depletion | 1 | 2013 | 129 | 0.030 |
Why?
| | Chemokine CXCL10 | 1 | 2012 | 34 | 0.020 |
Why?
| | Hydrolases | 1 | 2013 | 56 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2015 | 805 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2013 | 172 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 538 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 182 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 312 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2015 | 500 | 0.020 |
Why?
| | Tyrosine | 1 | 2012 | 218 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2020 | 1167 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 941 | 0.020 |
Why?
| | Metaplasia | 1 | 2011 | 54 | 0.020 |
Why?
| | Mucus | 1 | 2011 | 75 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2014 | 498 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 1825 | 0.020 |
Why?
| | Blood Glucose | 1 | 2020 | 2096 | 0.020 |
Why?
| | Th2 Cells | 1 | 2011 | 167 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 376 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2009 | 92 | 0.020 |
Why?
| | Rats, Inbred BN | 1 | 2009 | 53 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2009 | 81 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2320 | 0.020 |
Why?
| | Histocompatibility Testing | 1 | 2009 | 120 | 0.020 |
Why?
| | Transplantation, Isogeneic | 1 | 2008 | 17 | 0.020 |
Why?
| | Spleen | 1 | 2011 | 513 | 0.020 |
Why?
| | X-Linked Inhibitor of Apoptosis Protein | 1 | 2008 | 12 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2009 | 225 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2008 | 93 | 0.020 |
Why?
| | Isoxazoles | 1 | 2008 | 54 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1279 | 0.020 |
Why?
| | GTP-Binding Proteins | 1 | 2008 | 155 | 0.020 |
Why?
| | Administration, Oral | 1 | 2009 | 759 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 7065 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2009 | 813 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 1013 | 0.020 |
Why?
| | Postural Balance | 1 | 2008 | 199 | 0.020 |
Why?
| | Algorithms | 1 | 2013 | 1621 | 0.020 |
Why?
| | Pleura | 1 | 2005 | 22 | 0.020 |
Why?
| | Ligation | 1 | 2005 | 87 | 0.020 |
Why?
| | In Situ Nick-End Labeling | 1 | 2004 | 120 | 0.010 |
Why?
| | Mice, Inbred ICR | 1 | 2004 | 110 | 0.010 |
Why?
| | Pulmonary Embolism | 1 | 2005 | 208 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2008 | 823 | 0.010 |
Why?
| | Endopeptidases | 1 | 2003 | 83 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2004 | 402 | 0.010 |
Why?
| | Peptides | 1 | 2008 | 911 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2011 | 1924 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 10226 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1695 | 0.010 |
Why?
| | Child | 1 | 2017 | 20805 | 0.010 |
Why?
|
|
Petrache's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|